File photo of Indira Gandhi International Airport, one of the busiest in the world, in New Delhi, India, on November 2, 2016.
Nicolas Economou | NurPhoto | Getty Images
After shutting its borders to international visitors for 20 months due to the pandemic, India will now allow fully vaccinated foreign travelers from a list of nearly 100 countries to enter without the need to quarantine.
In guidelines updated last week, India said travelers arriving from these countries will be allowed to skip a post-arrival Covid test, but must monitor their health for the next 14 days.
As of Nov. 13, there were 99 countries on that list including the United States, U.K., Singapore, Australia, Germany, France and Brazil.
The countries on the list fall into two categories:
1. Those with reciprocal agreements with the Indian government to recognize each other’s vaccine certificates for either locally approved vaccines or those recognized by the World Health Organization;
2. and countries which do not have such agreements but that allow fully vaccinated Indian citizens to travel.
Visitors from countries that are not on the list will have to do a Covid test upon arrival, then spend 7 days in home quarantine and take another test on the 8th day, irrespective of their vaccination status.
Notable countries missing from that list of 99 countries include China, Japan, South Korea and Indonesia.
India’s Covid situation
India experienced a devastating second wave that peaked in early May. It pushed the country’s health-care system to the brink as Covid-19 cases soared and hospital beds and other medical supplies ran out. Since then, cases have been trending lower while vaccination rates have somewhat picked up.
Information collated by online publication, Our World In Data, showed that the 7-day rolling average of Covid cases per million people fell below 10 on Oct. 31 and has stayed that way as of Nov. 14. At its peak in May, that number was as high as 280.
Still, due to the limited testing, the number of confirmed cases remain lower than the actual number of infections.
Still, just under 40% of the eligible population has been fully vaccinated, falling below the pace needed to meet New Delhi’s previously announced target of inoculating every adult by the end of the year.
India has approved several vaccines since starting the inoculation program. They include the vaccine developed by AstraZeneca and Oxford University — locally known as Covishield and manufactured by the Serum Institute — as well as Bharat Biotech’s Covaxin, and Russia’s Sputnik-V.
Both Covishield and Covaxin have been approved for emergency use by the World Health Organization.